Skip to main content

Advertisement

SpringerLink
Log in

Suppression of herpes simplex virus 1 reactivation in a mouse eye model by cyclooxygenase inhibitor, heat shock protein inhibitor, and adenosine monophosphate

  • Review
  • Published:
Japanese Journal of Ophthalmology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Shimomura Y. Reactivation and latency of herpesvirus in the eye. Ophthalmologica 2001;215suppl 2:15–24.

    Article  PubMed  Google Scholar 

  2. Shimomura Y, Deai T, Fukuda M, Higaki S, Hooper LC, Hayashi K. Corneal buttons obtained from patients with HSK harbor high copy numbers of the HSV genome. Cornea 2007;26:190–193.

    Article  PubMed  Google Scholar 

  3. Herpetic Eye Disease Study Group. Acyclovir for the prevention of recurrent HSV eye disease. N Engl J Med 1998;339:300–306.

    Article  Google Scholar 

  4. Kaufman HE, Varnell ED, Gebhardt BM, Thompson HW, Hill JM. Propranolol suppression of ocular HSV-1 recurrence and associated corneal lesions following spontaneous reactivation in the rabbit. Curr Eye Res 1996;15:680–684.

    Article  CAS  PubMed  Google Scholar 

  5. Gebhardt BM, Wright GE, Xu H, Focher F, Spadari S, Kaufman HE. 9-(4-Hydroxybutyl)-N2-phenylguanine (HBPG), a thymidine kinase inhibitor, suppresses herpes virus reactivation in mice. Antiviral Res 1996;30:87–94.

    Article  CAS  PubMed  Google Scholar 

  6. Kaufman HE, Varnell ED, Gebhardt BM, et al. Efficacy of a heli-case-primase inhibitor in animal models of ocular herpes simplex virus type 1 infection. J Ocul Pharmacol Ther 2008;24:34–42.

    Article  CAS  PubMed  Google Scholar 

  7. Myles ME, Azcuy AM, Nguyen NT, et al. Bupropion (Zyban, Wellbutrin) inhibits nicotine-induced viral reactivation in herpes simplex virus type 1 latent rabbits. J Pharmacol Exp Ther 2004;311:640–644.

    Article  CAS  PubMed  Google Scholar 

  8. Kurane I, Tsuchiya Y, Sekizawa T, Kumagai K. Inhibition by indomethacin of in vitro reactivation of latent herpes simplex virus type 1 in murine trigeminal ganglia. J Gen Virol1984;65:1665–1674.

    Article  CAS  PubMed  Google Scholar 

  9. Gebhardt BM, Varnell ED, Kaufman HE. Inhibition of cyclooxygenase 2 synthesis suppresses herpes simplex virus type 1 reactivation. J Ocul Pharmacol Ther 2005;21:114–120.

    Article  CAS  PubMed  Google Scholar 

  10. Higaki S, Watanabe K, Itahashi M, Shimomura Y. Cyclooxygenase (COX)-inhibiting drug reduces HSV-1 reactivation in the mouse eye model. Curr Eye Res 2009;34:171–176.

    Article  CAS  PubMed  Google Scholar 

  11. Watanabe K. New therapy to reduce HSV-1 reactivation in mouse model. Kinki Univ Med J 2009;34:3–9.

    Google Scholar 

  12. Furuya A, Uozaki M, Yamasaki H, Arakawa T, Arita M, Koyama AH. Antiviral effects of ascorbic and dehydroascorbic acids in vitro. Int J Mol Med 2008;22:541–545.

    CAS  PubMed  Google Scholar 

  13. Femiano F, Gombos F, Scully C. Recurrent herpes labialis: a pilot study of the efficacy of zinc therapy. J Oral Pathol Med 2005;34:423–425.

    Article  CAS  PubMed  Google Scholar 

  14. Millhouse S, Kenny JJ, Quinn PG, Lee V, Wigdahl B. ATF/CREB elements in the herpes simplex virus type 1 latency-associated transcript promoter interact with members of the ATF/CREB and AP-1 transcription factor families. J Biomed Sci 1998;5:451–464.

    Article  CAS  PubMed  Google Scholar 

  15. Necklers LM. Can the heat shock protein 90 inhibitor geldanamycin be designed to specifically inhibit HER-2 tyrosine kinase? Drug Resist Updat 2000;3:203–205.

    Article  Google Scholar 

  16. Waterbury LD, Silliman D, Jolas T. Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium. Curr Med Res Opin 2006;22:1133–1140.

    Article  CAS  PubMed  Google Scholar 

  17. Sano M. Nonsteroidal anti-inflammatory drugs. Iyaku J 2003;39:83–97.

    Google Scholar 

  18. Banerjee K, Biswas PS, Rouse BT. Role of Stat4-mediated signal transduction events in the generation of aggressor CD4+ T cells in herpetic stromal keratitis pathogenesis. J Interferon Cytokine Res 2007;27:65–75.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Kinki University School of Medicine, Osaka, Japan

    Yoshikazu Shimomura, Shiro Higaki & Keizo Watanabe

  2. Kinki University School of Medicine, 377-2 Ono-Higashi, Osaka Sayama, Osaka, 589-8511, Japan

    Yoshikazu Shimomura

Authors
  1. Yoshikazu Shimomura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shiro Higaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Keizo Watanabe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoshikazu Shimomura.

About this article

Cite this article

Shimomura, Y., Higaki, S. & Watanabe, K. Suppression of herpes simplex virus 1 reactivation in a mouse eye model by cyclooxygenase inhibitor, heat shock protein inhibitor, and adenosine monophosphate. Jpn J Ophthalmol 54, 187–190 (2010). https://doi.org/10.1007/s10384-010-0803-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10384-010-0803-3

Keywords

Search

Navigation